What Dual Eligibles with Alzheimer’s Need to Know About Medicaid Changes

Learn how to keep Medicaid, keep your D-SNP drug help, and check 2026 care rules for Alzheimer's.

Dual eligibles with Alzheimer's need to keep Medicaid active through renewals to protect long-term care, cost-sharing help, and drug coverage. Dual eligibles are people covered by both Medicare and Medicaid, with Medicaid paying for services Medicare does not fully cover. Renewal paperwork now matters more because eligibility and funding changes are phasing in through 2026-2027. A missed renewal can end extra help with premiums, prescriptions, and managed-care coordination.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Table of Contents

Do new Medicaid work rules apply to you?

No. People over 65 and people dually eligible for Medicare are exempt from the new requirement. Starting by Jan. 1, 2027, Medicaid expansion adults ages 19-64 must document 80 hours per month of work, volunteering, school, or job training, as reported by ElderLawAnswers in its summary of the new Medicaid work rules.

That exemption is important for families with younger caregivers. A spouse or adult child on expansion Medicaid may still need to report activity every six months. Check whose coverage the notice covers before you respond. Keep proof of Medicare enrollment and age with renewal papers. If the state sends a work notice in error, respond promptly and keep copies.

What happens if Medicaid lapses at renewal?

Loss of Medicaid can end Dual Eligible Special Needs Plan membership and automatic Low-Income Subsidy for Part D. That forces a switch to a new Medicare Advantage or Part D plan and raises drug costs. The Medicare Rights Center reports that H.R.1, the 2025 budget reconciliation law, cuts about $1 trillion from Medicaid over ten years, with eligibility, renewal, and funding changes phasing in through 2026-2027, in its review of what is at stake in 2026.

For dual eligibles with Alzheimer's, the near-term risk is paperwork loss, not only policy change. CMS issued October 2026 guidance on enrollment and cost-sharing after loss of Medicaid. Ask your plan, State Health Insurance Assistance Program, or Medicaid office what special enrollment period applies and when new cost-sharing starts.

  • Open every renewal envelope and online account notice right away.
  • Return income, address, and asset proofs by the deadline.
  • Confirm Medicaid status before refilling prescriptions or scheduling care.

How are integrated Medicare-Medicaid plans changing?

The Medicare-Medicaid Plan demonstration ended Dec. 31, 2025. About 233,851 to 235,000 members in 12 states move to integrated Dual Eligible Special Needs Plans from Jan. 1, 2026, according to PlanFit summarizing CMS in its 2026 coverage update for dual members.

Some states auto-assign members to a new plan. Other states require active choice. Read the move letter for the deadline, doctor network, drug list, and care coordinator contact. For 2026, CMS also tightened integration rules for these plans. KFF reports that Fully Integrated plans must use exclusively aligned enrollment, described in its closer look at special needs plans in Medicare Advantage, meaning one company runs both the Medicare plan and Medicaid plan with one card and coordinator.

Which benefits and treatment rules should you check?

Check whether you are a full-benefit or partial-benefit dual eligible. Beginning in 2026, Special Supplemental Benefits for the Chronically Ill in D-SNPs, such as food, transportation, and dental allowances, are reserved for full-benefit dual eligibles. Partial duals with only Medicare Savings Program cost-sharing lose access to those allowances. Ask for a written benefit summary and use remaining 2025 allowances before they expire.

Care-access rules also vary by state. New York tightened managed long-term care entry, and treatment coverage has strict steps. Medicare Part B covers FDA-approved anti-amyloid drugs Leqembi and Kisunla only when the prescriber enrolls the patient in a CMS-approved registry, with 20 percent coinsurance that Medicaid covers for full duals and Medicare Savings Program members, subject to state rules. Confirm registry enrollment, infusion access, and coinsurance before starting treatment.


You Might Also Like

HelpDementia.com

Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance

© 2026 HelpDementia.com. All rights reserved.

Educational information only. It is not medical advice and does not replace care from a qualified clinician.